Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
Recruiting now · Phase 1
Conditions studied: Heart Failure With Preserved Ejection Fraction (HFpEF)
In brief
A Phase 1, Open label, Multiple Ascending Dose Study to Assess Safety and Tolerability of STM-01 in Participants with Heart Failure with Preserved Ejection Fraction (HFpEF)
Key facts
- Study ID
- NCT06560762
- Run by
- Secretome Therapeutics
- People needed
- 12
- Starts
- 2025-03-03
- Expected to finish
- 2025-12-15
- Last updated by the study team
- 2025-04-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- UT Southwestern Medical Center — Dallas, Texas, United States (enrolling)
- Northwestern Medicine — Chicago, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.